---
title: "WUXI LIFE has completed the issuance of 76.3584 million placement shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258654873.md"
description: "According to the announcement from WUXI LIFE, all conditions set forth in the placement agreement have been met, and the completion was implemented on September 24, 2025. The placement agent successfully placed a total of 76,358,400 placement shares at a placement price of HKD 0.59 per share to no fewer than 6 subscribers in accordance with the terms and conditions of the placement agreement"
datetime: "2025-09-24T08:34:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258654873.md)
  - [en](https://longbridge.com/en/news/258654873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258654873.md)
generator: "portal-rs"
---

# WUXI LIFE has completed the issuance of 76.3584 million placement shares

According to the announcement from WUXI LIFE (08148), all conditions set forth in the placement agreement have been met, and the completion was implemented on September 24, 2025. The placement agent has successfully placed a total of 76,358,400 placement shares at a placement price of HKD 0.59 per share to no fewer than 6 subscribers in accordance with the terms and conditions of the placement agreement

### Related Stocks

- [08148.HK](https://longbridge.com/en/quote/08148.HK.md)

## Related News & Research

- [Wuxi Life clarifies EGM proxy form title after translation error](https://longbridge.com/en/news/297532684.md)
- [Wuxi Life International schedules extraordinary general meeting](https://longbridge.com/en/news/297289857.md)
- [Hogs Continue Firmer Action on Wednesday](https://longbridge.com/en/news/297814949.md)
- [RemeGen Deploys Idle Funds Into Discloseable Wealth Management Products](https://longbridge.com/en/news/297779978.md)
- [13:01 ETTopDoctor Magazine Invites Physicians and Longevity Leaders to Biohackers World Chicago This Weekend](https://longbridge.com/en/news/297942843.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**